Latham & Watkins·FDA / LIFE SCIENCES REGULATORY

CMS Proposes RAPID Pathway to Combine FDA Approval, Medicare Coverage

The proposed RAPID pathway from the Centers for Medicare & Medicaid Services aims to shorten the gap between FDA device approval and Medicare coverage decisions from years to months.

cmsfdamedical-devicesrapid-pathwaymedicareregulatory-pathway
Read the original firm alert → Wednesday, September 23, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.